Cargando…

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS), the most common endocrine disorder in women of reproductive age, is characterized by androgen excess and ovarian dysfunction and presents with increased cardiometabolic risk factors such as obesity, insulin resistance, and elevated blood pressure (BP). We previously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres Fernandez, Edgar D, Adams, Kristen V, Syed, Maryam, Maranon, Rodrigo O, Romero, Damian G, Yanes Cardozo, Licy L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065488/ https://www.ncbi.nlm.nih.gov/pubmed/30087950 http://dx.doi.org/10.1210/js.2018-00131

Ejemplares similares

Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost?
por: Pruett, Jacob E, et al.
Publicado: (2021)

Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors
por: Pruett, Jacob E., et al.
Publicado: (2023)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021)

Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
por: Rezq, Samar, et al.
Publicado: (2021)

OR35-02 Novel Androgen Receptor PROTAC Degrader ARV-110 Ameliorates Androgen Mediated Renal Injury in a Mouse Model of Polycystic Ovary Syndrome
por: Basnet, Jelina, et al.
Publicado: (2023)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

Hepatic Dysregulation of Bile Acid Homeostasis in Hyperandrogenemic Female Mouse Model of Polycystic Ovary Syndrome
por: Huffman, Alexandra M, et al.
Publicado: (2021)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

MicroRNA-21 Modulates White Adipose Tissue Browning and Altered Thermogenesis in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2021)

Cardiovascular and Metabolic Consequences of Testosterone Supplements in Young and Old Male Spontaneously Hypertensive Rats: Implications for Testosterone Supplements in Men
por: Dalmasso, Carolina, et al.
Publicado: (2017)

Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
por: Romero, Damian G, et al.
Publicado: (2016)

Novel biomarkers of childhood and adolescent obesity
por: Yanes Cardozo, Licy L., et al.
Publicado: (2021)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women
por: Pruett, Jacob E, et al.
Publicado: (2022)

PMON225 Androgen excess in pre-menopausal women due to Granulosa Cell tumor: A case report.
por: Kaval, Roopitha, et al.
Publicado: (2022)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
por: Huffman, Alexandra M., et al.
Publicado: (2021)

SAT-361 Familial Hypocalciuric Hypercalcemia Type 3: AP2S1 Mutation
por: Kerut, Sarah Elizabeth, et al.
Publicado: (2020)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
por: Baldani, Dinka Pavicic, et al.
Publicado: (2015)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

OR35-01 Colonic Mitochondrial Dysfunction and Sub-acute Gastrointestinal Inflammation in Two Hyperandrogenemic Rodent Models of PCOS
por: Hoang, Ngoc, et al.
Publicado: (2023)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Androgen receptor gene mutations in 258 Han Chinese patients with polycystic ovary syndrome
por: Tian, Lifeng, et al.
Publicado: (2021)

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
por: Ding, Haigang, et al.
Publicado: (2021)

Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2022)

Visceral Adiposity Index: Simple Tool for Assessing Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
por: Agrawal, Hiya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_feunndpa11mvnnned7c7gkubos